1. Cochrane neurological sciences field corner

   • Teresa Anna Cantisani

   Editorial 12 July 2023 Pages: 2993 - 2994

   

2. Progressive multifocal leukoencephalopathy in multiple myeloma: a case report of a patient with SARS-CoV-2 infection and an updated systematic literature review

   • Matteo Paolucci
   • Luana Gentile
   • Andrea Zini

   COVID-19 08 July 2023 Pages: 2995 - 2998

   

3. Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis

   • Qian Zheng
   • Yongran Cheng
   • Zucai Xu

   COVID-19 27 May 2023 Pages: 2999 - 3003

   

4. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis

   • Heng Wei
   • Bin Fu
   • Ming Huang

   Review Article 15 April 2023 Pages: 3005 - 3015

   

5. Acute confusional state in HaNDL syndrome

   • Michele Trimboli
   • Letizia Troisi
   • Mariano Alberto Pennisi

   Review Article 03 April 2023 Pages: 3017 - 3028

   

6. Safety and efficacy of lithium in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis of randomized controlled trials

   • Abdullah Ashraf Hamad
   • Amir N. Attia
   • Mostafa Meshref

   Review Article 17 April 2023 Pages: 3029 - 3036

   

7. FDXR-associated disease: a challenging differential diagnosis with inflammatory peripheral neuropathy

   • Silvia Masnada
   • Roberto Previtali
   • Isabella Moroni

   Review Article 12 April 2023 Pages: 3037 - 3043

   

8. Safety and efficacy of cladribine in multiple sclerosis: a systematic review and meta-analysis

   • Fardin Nabizadeh
   • Mobin Mohamadi
   • Omid Mirmosayyeb

   Review Article 17 April 2023 Pages: 3045 - 3057

   

9. Fampridine for gait imbalance in patients with multiple sclerosis (MS): a systematic review and meta-analysis

   • Sahar Ghorbanpour
   • Sarvenaz Rahimibarghani
   • Mahsa Ghajarzadeh

   Review Article 14 April 2023 Pages: 3059 - 3069

   

10. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review

    • Łukasz Rzepiński
    • Pietro Emiliano Doneddu
    • Eduardo Nobile-Orazio

    Review Article 21 April 2023 Pages: 3071 - 3082

    

11. Is there a treatment effective and safe for sialorrhea in people with amyotrophic lateral sclerosis (ALS)? Summary of a Cochrane Systematic Review

    • Teresa Anna Cantisani

    Review Article 16 June 2023 Pages: 3083 - 3085

12. Functional connectivity reveals different brain networks underlying the idiopathic foreign accent syndrome

    • Nicholas B. Dadario
    • Keaton Piper
    • Michael E. Sughrue

    Original Article 30 March 2023 Pages: 3087 - 3097

    

13. Evaluation of apathy in non-clinical populations: validation, psychometric properties, and normative data of the Italian version of Apathy-Motivation Index (AMI)

    • Manuela Altieri
    • Gianpaolo Maggi
    • Gabriella Santangelo

    Original Article Open access 03 April 2023 Pages: 3099 - 3106

    

14. Behavioral scales variability in patients with prolonged disorders of consciousness

    • Maria Daniela Cortese
    • Martina Vatrano
    • Francesco Riganello

    Original Article Open access 22 April 2023 Pages: 3107 - 3122

    

15. Exploring depression in Parkinson’s disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management

    • Fabrizio Stocchi
    • Angelo Antonini
    • Alessandro Padovani

    Original Article Open access 27 April 2023 Pages: 3123 - 3131

16. Assessment of the psychometric properties of the Italian version of the New Freezing of Gait Questionnaire (NFOG-Q-IT) in people with Parkinson disease: a validity and reliability study

    • Susanna Mezzarobba
    • Carola Cosentino
    • Elisa Pelosin

    Original Article Open access 18 April 2023 Pages: 3133 - 3140

    

17. Parkinson’s disease patients combined with constipation tend to have higher serum expression of microRNA 29c, prominent neuropsychiatric disorders, possible RBD conversion, and a substandard quality of life

    • Hong Liu
    • Lei Shen
    • Dongya Huang

    Original Article 17 April 2023 Pages: 3141 - 3150

    

18. Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort

    • Roberta Bovenzi
    • Matteo Conti
    • Tommaso Schirinzi

    Original Article Open access 04 May 2023 Pages: 3151 - 3159

    

19. Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort

    • Beatrice Orso
    • Pietro Mattioli
    • Dario Arnaldi

    Original Article Open access 04 May 2023 Pages: 3161 - 3168

    

20. A complex interplay between autonomic symptoms and symptoms of depression, anxiety, and stress

    • Anamari Junaković
    • Milena Skočić Hanžek
    • Mario Habek

    Original Article 04 April 2023 Pages: 3169 - 3179

    

21. Clinical usability of the Story-Based Empathy Task (SET) in non-demented ALS patients

    • Edoardo Nicolò Aiello
    • Federica Solca
    • Barbara Poletti

    Original Article 05 April 2023 Pages: 3181 - 3187

22. The clinical characteristics of neuronal intranuclear inclusion disease and its relation with inflammation

    • Yaping Yan
    • Lanxiao Cao
    • Guohua Zhao

    Original Article 26 April 2023 Pages: 3189 - 3197

    

23. Bringing door-to-needle times within the European benchmarks results in better stroke patients outcomes in a spoke hospital from the Apulian Region

    • Maurizio Giorelli
    • Ruggiero Leone
    • Alessandro Scelzi

    Original Article 06 May 2023 Pages: 3199 - 3207

    

24. A visualized MAC nomogram online predicts the risk of three-month mortality in Chinese elderly aneurysmal subarachnoid hemorrhage patients undergoing endovascular coiling

    • Zhou Zhou
    • Wei Lu
    • ZhiHong Zhao

    Original Article 05 April 2023 Pages: 3209 - 3220

    

25. The association between white matter tract structural connectivity and information processing speed in relapsing-remitting multiple sclerosis

    • Magdalena Chylińska
    • Bartosz Karaszewski
    • Agnieszka Sabisz

    Original Article Open access 27 April 2023 Pages: 3221 - 3232

    

26. Fall risk is related to cognitive functioning in ambulatory multiple sclerosis patients

    • Yaprak Ozum Unsal Bilgin
    • Asli Koskderelioglu
    • Muhtesem Gedizlioglu

    Original Article 30 March 2023 Pages: 3233 - 3242

    

27. Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis

    • Foraysa Talaat
    • Sahar Abdelatty
    • Ahmed Dahshan

    Original Article Open access 29 March 2023 Pages: 3243 - 3252

    

28. Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis

    • Jingfang Lin
    • Jierui Wang
    • Jinmei Li

    Original Article 03 April 2023 Pages: 3253 - 3259

    

29. Reversible large-scale network disruption correlates with neurocognitive improvement in HIV-associated minor neurocognitive disorder with combined anti-retroviral therapy intensification: a prospective longitudinal resting-state functional magnetic resonance imaging study

    • Joga Chaganti
    • Thomas M. Gates
    • Bruce J. Brew

    Original Article 13 April 2023 Pages: 3261 - 3269

    

30. CSF-based liquid biopsy pointing to a diagnosis of diffuse glioma in a patient with supposed neurodegenerative disorder

    • Valentina Pieri
    • Davide Gusmeo Curti
    • Massimo Filippi

    Original Article 17 April 2023 Pages: 3271 - 3277

    

31. An S-like curve relationship between systemic inflammation response index (SIRI) and respiratory failure in GBS patients

    • Qiuyan Shen
    • Xin Mu
    • Yanming Xu

    Original Article 20 April 2023 Pages: 3279 - 3285

    

32. Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer’s disease

    • Federico Verde
    • Ilaria Milone
    • Nicola Ticozzi

    Brief Communication 07 June 2023 Pages: 3287 - 3290

    

33. Pre-existing frontal lobe dysfunction signs as predictors of subsequent neurotoxicity in CAR T cell therapy: insights from a case series

    • Lorenzo Fontanelli
    • Chiara Pizzanelli
    • Filippo Baldacci

    Brief Communication 10 May 2023 Pages: 3291 - 3297

    

34. A novel CACNA1A R2201W variant in a woman with hemiplegic migraine

    • Giacomo Baso
    • Francesco Mele
    • Leonardo Pantoni

    Brief Communication 06 May 2023 Pages: 3299 - 3302

    

35. An SPG7 mutation as a novel cause of monogenic progressive muscular atrophy

    • Ângela Pereira
    • Nataliya Tkachenko
    • Jorge Diogo Da Silva

    Brief Communication 22 May 2023 Pages: 3303 - 3305

36. Models of care in emergency neurology: from the Neuro Fast Track to the emergency neurologist—a position paper of the Italian Association for Emergency Neurology (ANEU)

    • Giuseppe Micieli
    • Pietro Cortelli
    • Giovanni Maria Franco

    Consensus papers and Guidelines 29 June 2023 Pages: 3307 - 3317

    

37. The political discourse on Alzheimer’s disease and related dementias: a Twitter content analysis

    • Fausto Roveta
    • Alberto Grassini
    • Innocenzo Rainero

    Letter to the Editor 13 April 2023 Pages: 3319 - 3320

38. Amyloid-β, vitamin D: why we should triangulate conclusions about therapeutic targets in Alzheimer’s disease

    • Timothy Daly

    Letter to the Editor 05 May 2023 Pages: 3321 - 3322

39. A case of childhood-onset dystonia-parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation

    • Federica Garrì
    • Dario Ciprietti
    • Angelo Antonini

    Letter to the Editor 10 May 2023 Pages: 3323 - 3326

    

40. Frontotemporal dementia phenotype in late-onset Huntington disease without chorea

    • Giulia Bonato
    • Stefano Mozzetta
    • Annachiara Cagnin

    Letter to the Editor 04 May 2023 Pages: 3327 - 3329

    

41. The one-and-a-half syndrome: a distinctive clinical finding in a patient with multiple sclerosis

    • Enrico Fratto
    • Stefania Barone
    • Paola Valentino

    Letter to the Editor 26 April 2023 Pages: 3331 - 3333

    

42. CNS demyelination associated with nilotinib

    • Ezgi Erturul
    • Belgin Kocer
    • Murat Ucar

    Letter to the Editor 03 May 2023 Pages: 3335 - 3339

    

43. Subacute cognitive impairment in B12 vitamin-deficiency neuromyelopathy secondary to nitrous oxide abuse

    • Timour Vitte
    • Anna Castrioto
    • Sina R. Potel

    Letter to the Editor 03 May 2023 Pages: 3341 - 3343

    

44. Myasthenia gravis-myositis association: is it an overlap myositis or a distinct entity?

    • Sohyeon Kim
    • Mi-Yeon Eun
    • Hung Youl Seok

    Letter to the Editor 13 May 2023 Pages: 3345 - 3346

45. Post-traumatic myasthenia gravis with head drop: insights into pathogenesis

    • Shadi El-Wahsh
    • James Triplett
    • Con Yiannikas

    Letter to the Editor 17 April 2023 Pages: 3347 - 3349

    

46. Contralateral knee sign: an extension of the Hoover's sign to unveil functional paralysis of knee extension

    • Francesco Brigo

    Letter to the Editor 12 May 2023 Pages: 3351 - 3352

47. Transient ischemic attack due to dynamic evolution of carotid artery web

    • Hui Zhang
    • Nianlong Sun
    • Yitao He

    Neuro-Images 15 April 2023 Pages: 3353 - 3354

    

48. Sudden-onset headache due to reversible cerebral vasoconstriction syndrome

    • Jion Goto
    • Yoshifusa Abe
    • Shuichiro Watanabe

    Neuro-Images Open access 23 May 2023 Pages: 3355 - 3356

    

49. Claustrum sign in febrile infection-related epilepsy syndrome (FIRES)

    • Kundian Guo
    • Zhen Hong

    Neuro-Images 05 June 2023 Pages: 3357 - 3359

    

50. Hyperammonemic encephalopathy

    • Santiago Aristizábal-Ortiz
    • Silvia Márquez-Zuchini
    • Angela Guarnizo

    Neuro-Images 13 June 2023 Pages: 3361 - 3362